We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Prostate cancer is the most commonly diagnosed tumour in adult men in developed countries where there is a long life expectancy. It is an atypical and uncontrolled growth of the cells that make up the prostate gland.
If left untreated, the cancerous prostate cells can end up spreading to and invading distant parts of the body - especially lymph nodes and bones - and cause secondary tumours through a process known as metastasis.
Due to widespread knowledge of this tumour in the general population and the ease with which suspicion is established, 90% of cases in Spain are diagnosed when the cancer is still at a localised stage. This diagnosis is established by means of a blood analysis and rectal examination.
Some of the risk factors for this disease include:
Many men with prostate cancer are asymptomatic.
Often, the first sign of the disease is a chance finding of elevated prostate-specific antigen (PSA) levels in a routine blood test. The disease may occasionally produce local symptoms related to prostate gland growth that may mimic those caused by benign prostatic hyperplasia (BPH). In these patients, bone pain is often related to more advanced stages of pancreatic cancer.
Experiencing urinary discomfort does not necessarily mean that you have prostate cancer. Consult your doctor if you have any of these symptoms to make sure that you receive a proper diagnosis and course of treatment.
Prostate biopsies can cause some complications, but most of the time there are no sequelae. The most frequent ones are:
Depending on the aggressiveness of the tumour, the urologist will order the necessary complementary imaging tests to ascertain the clinical stage of the cancer. These tests may be: a computed axial tomography (CT) scan, a bone scan, a multiparametric MRI scan of the prostate or a positron emission tomography (PET) scan.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.